KIM-1 (kidney injury molecule 1) is a transmembrane glycoprotein also known as HAVcr-1
and TIM-1 belongs to the T-cell immunoglobulin and mucin domain family (TIM) of proteins …

Abstract Kidney Injury Molecule-1 (KIM-1), also known as T cell immunoglobulin and mucin
domain-1 (TIM-1), is a widely recognized biomarker for acute kidney injury, but its biological …

Purpose: Renal cell carcinoma (RCC) has the potential for cure with surgery when
diagnosed at an early stage. Kidney injury molecule-1 (KIM-1) has been shown to be …

Purpose: No circulating biomarkers are currently available to identify patients at highest risk
of recurrence after nephrectomy for renal cell carcinoma (RCC). Kidney injury molecule-1 …

Background T-cell immunoglobulin and mucin domain 1 (TIM-1) is an important co-
stimulatory molecule which serves as a surface marker for T cell activation, especially for …

Abstract Cytochrome C (Cyto C), a multifunctional enzyme, has been demonstrated to be
associated with cell apoptosis and respiration. Accumulating evidence has revealed that …

T-cell immunoglobulin and mucin structural domain 1 (TIM-1, also known as hepatitis A virus
cell receptor 1) is a co-stimulatory molecule that is expressed predominantly on the surface …

Kidney injury is the main cause of mortality and morbidity globally. The kidney injury
molecule (KIM-1) is a type 1 transmembrane protein, which is been upregulated during renal …

Metastasis is present in approximately 30% of patients diagnosed with renal cell carcinoma
(RCC) and is associated with a 5-year survival rate of< 15%. Kidney injury molecule 1 (KIM …

Despite rapid advances in diagnostic and therapeutic medicine, renal cell carcinoma (RCC)
continues to cause significant morbidity and mortality in patients. While there has been a …